Novartis receives binding offer from Siemens Healthineers for molecular imaging business
(Reuters) -Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans. The German health technology company will pay more than 200 million euros ($224 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned …
Novartis receives binding offer from Siemens Healthineers for molecular imaging business Read More »










